Geninnov

Healthcare

February 9, 2026

Shedding the Skin of Scandal: The Unbridled Paradox of Chinese Drug Discovery

Massive reforms, global deals and proven FDA approvals suggest Chinese clinical data deserves far more credit than skeptical markets allow.

January 29, 2026

China’s Pharma Foundry

The untold story of how contract labs became a pharmaceutical superpower. China didn't just join the drug discovery race; it rewrote the rules.

Archisha Mukherjee

January 22, 2026

The Accelerationist State: China’s Biopharma Industrialization

China’s biopharma surge is policy-made: statutory clocks, silent approvals, and scaled expertise—creating a pipeline too fast to ignore

November 2, 2025

Takeda Blinked. Markets Didn’t. China’s Quiet Big-Pharma Break-In

Chinese pharma's breakthroughs are upending many important drivers and notions of the whole global healthcare industry

AI’s Uneven Progress in Healthcare Subsegments

We evaluate five segments for the impact of AI, and feel that instrumentations may see the earliest winners

Articles on innovation

Our Latest Articles

Goliath’s World and the Encroachment Imperative

When physics demands integration, modularity becomes a liability. That is the hardware industry's problem now.

Optical Rivalries: Where One Tech Must Lose for the Other to Win

The red-hot interconnect space is not only small but endlessly self-cannibalizing, with many incompatible narratives

Five Certainties in the AI Storm: Beyond Hope and Hype

AI’s impact won’t be announced by a gradual S-curve. Using five indisputable priors, we arrive at five near-certain realities staring at us